Uae Insulin Pumps Market is Expected to Register Robust Growth in the Forecast Period, 2023-2027.
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Rise in the Prevalence of Diabetes Fuels the Growth of the Insulin Pump Market
Diabetes refers to a clinical condition where the pancreas is not able to produce insulin which lowers the glucose levels in the body. The changing lifestyle such as the consumption of alcohol and smoking are propelling the increase in the number of diabetes patients across UAE. With this, the growing prevalence of obesity is accelerating diabetes cases across the region which is acting as another growth-inducing factor. Type 1 diabetes requires continuous monitoring of blood glucose along with numerous injections of insulin, thereby augmenting the growth of insulin pumps and other insulin delivery devices and glucose monitors.Increase in Use of Insulin Pumps Over Traditional Therapies Propels the Market Growth
The rising popularity of insulin pumps as it eliminates inconvenience for the patient by delivering the medication as per the recommendations of the doctor. The Cannula of the pump is inserted into the skin to fulfill the need for frequent injections. Insulin supply can be adjusted on these pumps as per the requirement of an individual. This, in turn, reduces the probability of the occurrence of hypoglycemic episodes in the morning or a sudden rise in blood glucose levels which is expected to accelerate the growth of the UAE insulin pump market.Incorporation of Advanced Technologies Promotes the Market Growth
Advanced technologies such as artificial intelligence (AI) are encouraging the adoption of automated insulin pumps in the upcoming years. In addition to this, the latest insulin pumps are facilitating smartphones to relate to the insulin pumps and are providing control of doses and acting as a blood glucose monitoring device. These technological advancements are fueling the transitions from traditional insulin injections to more efficient and convenient pumps which offer greater patient satisfaction.Market Segmentation
The UAE Insulin Pumps market is segmented into type, insulin used, application, end user, regional distribution, and competitive landscape. Based on type, the market is bifurcated into traditional insulin pumps and patch pumps. Based on insulin used, the market is segmented into short-acting insulin and rapid-acting insulin. Based on application, the market is divided into type 1 diabetes and type 2 diabetes. Based on end users, the market is segmented into hospitals & clinics, diagnostic centers, and home care. To analyze the market based on the region, the UAE Insulin Pumps market is studied in major regions namely Dubai, Abu Dhabi, Sharjah, Rest of UAE.Market Players
Medtronic Meta FZ-LLC, Roche UAE, Abbott Laboratories, S.A., Nipro Middle East FZE, B. Braun Medical Gulf Fz-LLC, Terumo Middle East FZE, Becton, Dickinson, and Company are the key market players operating in UAE Insulin Pumps market.Report Scope:
In this report, UAE Insulin Pumps market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:UAE Insulin Pumps Market, By Type:
- Traditional Insulin Pumps
- Patch Pumps
UAE Insulin Pumps Market, By Insulin Used:
- Short-Acting Insulin
- Rapid Acting Insulin
UAE Insulin Pumps Market, By Application:
- Type 1 Diabetes
- Type 2 Diabetes
UAE Insulin Pumps Market, By End User:
- Hospitals & Clinics
- Diagnostic Centers
- Home Care
UAE Insulin Pumps, By Region:
- Dubai
- Abu Dhabi
- Sharjah
- Rest of the UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in UAE Insulin Pumps market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic Meta FZ-LLC
- Roche UAE
- Abbott Laboratories, S.A.
- Nipro Middle East FZE
- B. Braun Medical Gulf Fz-LLC
- Terumo Middle East FZE
- Becton, Dickinson, and Company